SEC Form 4
FORM 4 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
| |||||||||||||||
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). |
1. Name and Address of Reporting Person*
(Street)
| 2. Issuer Name and Ticker or Trading Symbol Inspire Medical Systems, Inc. [ INSP ] | 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)
| ||||||||||||||||||||||||
3. Date of Earliest Transaction (Month/Day/Year) 05/07/2018 | ||||||||||||||||||||||||||
4. If Amendment, Date of Original Filed (Month/Day/Year) | 6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 05/07/2018 | C | 360,902 | A | (1)(2) | 360,902 | I | By KPCB Holdings, Inc., as nominee(3) | ||
Common Stock | 05/07/2018 | C | 389,893 | A | (1)(4) | 750,795 | I | By KPCB Holdings, Inc., as nominee(3) | ||
Common Stock | 05/07/2018 | C | 472,581 | A | (1)(2) | 1,223,376 | I | By KPCB Holdings, Inc., as nominee(3) | ||
Common Stock | 05/07/2018 | C | 210,147 | A | (1)(2) | 1,433,523 | I | By KPCB Holdings, Inc., as nominee(3) | ||
Common Stock | 05/07/2018 | C | 163,962 | A | (1)(5) | 1,597,485 | I | By KPCB Holdings, Inc., as nominee(3) | ||
Common Stock | 05/07/2018 | C | 339,759 | A | (1)(2) | 1,937,244 | I | By KPCB Holdings, Inc., as nominee(3) |
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Series A Convertible Preferred Stock | (1)(2) | 05/07/2018 | C | 2,400,000 | (1) | (1) | Common Stock | 360,902 | $0.00 | 0 | I | By KPCB Holdings, Inc., as nominee(3) | |||
Series B Convertible Preferred Stock | (1)(4) | 05/07/2018 | C | 2,102,315 | (1) | (1) | Common Stock | 389,893 | $0.00 | 0 | I | By KPCB Holdings, Inc., as nominee(3) | |||
Series C Convertible Preferred Stock | (1)(2) | 05/07/2018 | C | 3,142,670 | (1) | (1) | Common Stock | 472,581 | $0.00 | 0 | I | By KPCB Holdings, Inc., as nominee(3) | |||
Series D Convertible Preferred Stock | (1)(2) | 05/07/2018 | C | 1,397,478 | (1) | (1) | Common Stock | 210,147 | $0.00 | 0 | I | By KPCB Holdings, Inc., as nominee(3) | |||
Series E Convertible Preferred Stock | (1)(5) | 05/07/2018 | C | 948,855 | (1) | (1) | Common Stock | 163,962 | $0.00 | 0 | I | By KPCB Holdings, Inc., as nominee(3) | |||
Series F Convertible Preferred Stock | (1)(2) | 05/07/2018 | C | 2,259,399 | (1) | (1) | Common Stock | 339,759 | $0.00 | 0 | I | By KPCB Holdings, Inc., as nominee(3) |
1. Name and Address of Reporting Person*
(Street)
| ||||||||||||
1. Name and Address of Reporting Person*
(Street)
| ||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
Explanation of Responses: |
1. Shares of Series A, Series B, Series C, Series D, Series E and Series F Convertible Preferred Stock (collectively, the "Convertible Preferred Stock") have no expiration date and were automatically converted into shares of Common Stock for no additional consideration immediately prior to the closing of the Issuer's initial public offering. |
2. Shares of Series A, Series C, Series D and Series F Convertible Preferred Stock are convertible into shares of Common Stock at a 1-for-0.1504 conversion rate. |
3. Consists of shares beneficially owned by Kleiner Perkins Caufield & Byers XII, LLC ("KPCB XII"), KPCB XII Founders Fund, LLC ("KPCB XII FF"), and individuals and entities associated with Kleiner Perkins Caufield & Byers. All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee" for the accounts of such individuals and entities. The managing member of KPCB XII and KPCB XII FF is KPCB XII Associates, LLC ("KPCB XII Associates"). Brook Byers, L. John Doerr, Raymond Lane and Theodore Schlein, the managers of KPCB XII Associates, exercise shared voting and dispositive control over the shares held by KPCB XII and KPCB XII FF. KPCB XII and each of its managers disclaim beneficial ownership of such shares except to the extent of any pecuniary interest therein. |
4. Shares of Series B Convertible Preferred Stock are convertible into shares of Common Stock at a 1-for-0.1855 conversion rate. |
5. Shares of Series E Convertible Preferred Stock are convertible into shares of Common Stock at a 1-for-0.1728 conversion rate. |
/s/ Susan Biglieri, Chief Financial Officer | 05/09/2018 | |
/s/ Susan Biglieri, Chief Financial Officer | 05/09/2018 | |
/s/ Susan Biglieri, Chief Financial Officer | 05/09/2018 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |